POCYTON

A Novel Detection Scheme to Enable Point of Care Flow Cytometry

 Coordinatore FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Germany [DE]
 Totale costo 1˙427˙825 €
 EC contributo 1˙427˙825 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2010-StG_20091028
 Funding Scheme ERC-SG
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-01-01   -   2015-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    INSTITUT FUER MIKROTECHNIK MAINZ GMBH

 Organization address address: Carl-Zeiss-Str. 18-20
city: Mainz
postcode: 55129

contact info
Titolo: Dr.
Nome: Frank
Cognome: Hainel
Email: send email
Telefono: 496132000000
Fax: 496132000000

DE (Mainz) beneficiary 737˙081.44
2    FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V

 Organization address address: Hansastrasse 27C
city: MUENCHEN
postcode: 80686

contact info
Titolo: Dr.
Nome: Michael
Cognome: Baßler
Email: send email
Telefono: 496132000000
Fax: 496132000000

DE (MUENCHEN) hostInstitution 690˙743.56
3    FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V

 Organization address address: Hansastrasse 27C
city: MUENCHEN
postcode: 80686

contact info
Titolo: Ms.
Nome: Andrea
Cognome: Zeumann
Email: send email
Telefono: +49 89 12052723
Fax: +49 89 12057534

DE (MUENCHEN) hostInstitution 690˙743.56

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

made    alignment    miniaturization    flow    pocyton    narrow    clinical    cell    coded    signal    cytometry    precision    detection    components    excitation    zone   

 Obiettivo del progetto (Objective)

'In PoCyton, a revolutionary concept for the detection zone of a flow cytometer is proposed. Flow cytometers are fluorescence-based cell counters and as such are indispensable instruments in clinical and biomedical research. Over the last four decades, despite gradual technical improvements in the constituent components, the detection principle has virtually remained unchanged. Fluorescently tagged cells in suspension are made to flow through a narrow focal excitation area and then detected via the fluorescent pulse emitted by them. The narrow focus imposes restrictions on the flow rate and, as a consequence, on feasible sample volumes. Moreover, the alignment of cell-flow, excitation, and detection requires extreme precision. To this end, expensive, bulky components have to be used, preventing substantial miniaturization of flow cytometry. In PoCyton, the detection zone will be enlarged and superimposed with a pseudo-random pattern leading to a temporally extended, distinctly coded signal recorded for each fluorescing cell. In analogy to spread-signal methods, each cell will be reconstructed from the coded signal by correlation techniques. While the precision in spatial cell discrimination outperforms that of conventional flow cytometry only slightly, the signal-to-noise ratio is enhanced significantly, resulting in a notable improvement in sensitivity. In addition, the enlargement of the detection zone dramatically mitigates alignment issues. In PoCyton, various implementations and extensions towards multi-colour flow cytometry will be studied experimentally to demonstrate their high sample-throughput and miniaturization (lab-on-a-chip) potential. Ultimately, a wider range of flow cytometry methods will thus be made available for routine use in clinical laboratories and medical point-of-care diagnosis, e.g., for cancer treatment. PoCyton is a multi-disciplinary project primarily involving expertise in optics, microfluidics, micro-systems, and signal processing.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

ROMOL (2013)

Riding on Moore's Law

Read More  

LIPIDOLIV (2014)

Role of the transcription factor ChREBP and its associated proteins in the development and progression of NAFLD

Read More  

CANCERINNOVATION (2012)

Using novel methodologies to target and image cancer invasion and therapeutic resistance

Read More